Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Care | Research article

Longitudinal evaluation of Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a symptom screening and management application

Authors: Emily Vettese, Sadie Cook, Dilip Soman, Susan Kuczynski, Brenda Spiegler, Hailey Davis, Nathan Duong, Tal Schechter, L. Lee Dupuis, Lillian Sung

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK) is a web application focused on improving symptom control. It enables pediatric cancer and hematopoietic stem cell transplant (HSCT) patients to self-report and track symptoms, and allows healthcare professionals to access guidelines for symptom management. Objective was to determine the feasibility of longitudinal collection of symptom data.

Methods

In this longitudinal, single-armed feasibility study, respondents were children 8–18 years of age with cancer or pediatric HSCT recipients. Participants completed symptom reporting daily for 5 days. Cognitive interviews were conducted on day 5. Quantitative evaluation included SPARK ease of use and understandability of SPARK reports. Qualitative feedback on facilitators and barriers to daily symptom screening was solicited. Feasibility was defined as ≥75% of participants completing symptom screening on at least 60% of on-study days during the five-day study.

Results

Among the 30 children enrolled, the median number of days SSPedi was completed at least once was 5 (range 3 to 5). Overall, 28/29 (96.6%) thought completing symptom screening using SPARK was easy or very easy. All participants understood SPARK symptom reports. Severe symptoms was the most common barrier to daily reporting while an alarm reminder system was the most commonly identified facilitator.

Conclusions

Daily completion of symptom screening using SPARK over 5 days was feasible in children aged 8 to 18 years with cancer and pediatric HSCT recipients. SPARK is now appropriate for use in randomized trials to evaluate the effect of symptom screening and symptom feedback.
Literature
1.
go back to reference Dupuis LL, Johnston DL, Baggott C, Hyslop S, Tomlinson D, Gibson P, et al. Validation of the symptom screening in pediatrics tool in children receiving cancer treatments. J Natl Cancer Inst. 2018;110(6):661–8.CrossRefPubMed Dupuis LL, Johnston DL, Baggott C, Hyslop S, Tomlinson D, Gibson P, et al. Validation of the symptom screening in pediatrics tool in children receiving cancer treatments. J Natl Cancer Inst. 2018;110(6):661–8.CrossRefPubMed
2.
go back to reference Johnston DL, Hyslop S, Tomlinson D, Baggott C, Gibson P, Orsey A, et al. Describing symptoms using the symptom screening in pediatrics tool in hospitalized children with cancer and hematopoietic stem cell transplant recipients. Cancer Med. 2018;7(5):1750–5.CrossRefPubMedPubMedCentral Johnston DL, Hyslop S, Tomlinson D, Baggott C, Gibson P, Orsey A, et al. Describing symptoms using the symptom screening in pediatrics tool in hospitalized children with cancer and hematopoietic stem cell transplant recipients. Cancer Med. 2018;7(5):1750–5.CrossRefPubMedPubMedCentral
3.
go back to reference O'Sullivan C, Dupuis LL, Sung L. A review of symptom screening tools in pediatric cancer patients. Curr Opin Oncol. 2015;27(4):285–90.CrossRefPubMed O'Sullivan C, Dupuis LL, Sung L. A review of symptom screening tools in pediatric cancer patients. Curr Opin Oncol. 2015;27(4):285–90.CrossRefPubMed
4.
go back to reference Dupuis LL, Ethier MC, Tomlinson D, Hesser T, Sung L. A systematic review of symptom assessment scales in children with cancer. BMC Cancer. 2012;12:430.CrossRefPubMedPubMedCentral Dupuis LL, Ethier MC, Tomlinson D, Hesser T, Sung L. A systematic review of symptom assessment scales in children with cancer. BMC Cancer. 2012;12:430.CrossRefPubMedPubMedCentral
5.
go back to reference Tomlinson D, Dupuis LL, Gibson P, Johnston DL, Portwine C, Baggott C, et al. Initial development of the symptom screening in pediatrics tool (SSPedi). Supp Care Cancer. 2014;22(1):71–5.CrossRef Tomlinson D, Dupuis LL, Gibson P, Johnston DL, Portwine C, Baggott C, et al. Initial development of the symptom screening in pediatrics tool (SSPedi). Supp Care Cancer. 2014;22(1):71–5.CrossRef
6.
go back to reference O'Sullivan C, Dupuis LL, Gibson P, Johnston DL, Baggott C, Portwine C, et al. Refinement of the symptom screening in pediatrics tool (SSPedi). BJC. 2014;111(7):1262–8.CrossRefPubMed O'Sullivan C, Dupuis LL, Gibson P, Johnston DL, Baggott C, Portwine C, et al. Refinement of the symptom screening in pediatrics tool (SSPedi). BJC. 2014;111(7):1262–8.CrossRefPubMed
7.
go back to reference O'Sullivan C, Dupuis L, Gibson P, Johnston DL, Baggott C, Portwine C, et al. Evaluation of the electronic self-report symptom screening in pediatrics tool (SSPedi). BMJ Support Palliat Care. 2018;8(1):110–6.CrossRefPubMed O'Sullivan C, Dupuis L, Gibson P, Johnston DL, Baggott C, Portwine C, et al. Evaluation of the electronic self-report symptom screening in pediatrics tool (SSPedi). BMJ Support Palliat Care. 2018;8(1):110–6.CrossRefPubMed
8.
go back to reference Cook S, Vettese E, Soman D, Hyslop S, Kuczynski S, Spiegler B, et al. Initial development of supportive care assessment, prioritization and recommendations for kids (SPARK), a symptom screening and management application. BMC Med Inform Decis Mak. 2019;19(1):9.CrossRefPubMedPubMedCentral Cook S, Vettese E, Soman D, Hyslop S, Kuczynski S, Spiegler B, et al. Initial development of supportive care assessment, prioritization and recommendations for kids (SPARK), a symptom screening and management application. BMC Med Inform Decis Mak. 2019;19(1):9.CrossRefPubMedPubMedCentral
9.
go back to reference Thaler RH, Sunstein CR. Nudge: improving decisions about health, wealth and happiness. New York: Penguin Publishing Group; 2009. Thaler RH, Sunstein CR. Nudge: improving decisions about health, wealth and happiness. New York: Penguin Publishing Group; 2009.
10.
go back to reference Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.CrossRefPubMed Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.CrossRefPubMed
11.
go back to reference Berry DL, Hong F, Halpenny B, Partridge AH, Fann JR, Wolpin S, et al. Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014;32(3):199–205.CrossRefPubMed Berry DL, Hong F, Halpenny B, Partridge AH, Fann JR, Wolpin S, et al. Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014;32(3):199–205.CrossRefPubMed
13.
go back to reference Dupuis LL, Kelly KM, Krischer JP, Langevin AM, Tamura RN, Xu P, et al. Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: a single-blinded, randomized controlled trial. Cancer. 2018;124(6):1188–96.CrossRefPubMed Dupuis LL, Kelly KM, Krischer JP, Langevin AM, Tamura RN, Xu P, et al. Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: a single-blinded, randomized controlled trial. Cancer. 2018;124(6):1188–96.CrossRefPubMed
Metadata
Title
Longitudinal evaluation of Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a symptom screening and management application
Authors
Emily Vettese
Sadie Cook
Dilip Soman
Susan Kuczynski
Brenda Spiegler
Hailey Davis
Nathan Duong
Tal Schechter
L. Lee Dupuis
Lillian Sung
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5662-9

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine